Arcutis Announces Second Quarter 2023 Financial Results and Provides Business Update tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
21.11.2022 - Report highlights efforts to advance diversity and inclusion, access to medicine, sustainable business practices, and governance WESTLAKE VILLAGE, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) - Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), an .
First exit for LifeArc Ventures, the largest investor in Ducentis, recognising the transformational potential of its scienceDucentis lead pre-clinical asset DS-234 is being developed for the
Arcutis Biotherapeutics Inc (ARQT) Appoints Neha Krishnamohan to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.